New Software Demonstrates Effectiveness in Reducing Unnecessary Medication Use Among Seniors

A new clinical trial highlights an innovative digital tool that helps healthcare providers deprescribe unnecessary medications for seniors, improving safety and quality of life in long-term care.
Recent clinical research from McGill University has showcased a promising digital tool designed to improve medication management in older adults residing in long-term care facilities. This innovative software, known as MedSafer, acts as a decision support system for healthcare providers by analyzing patients' medication lists in conjunction with their health conditions. It flags potentially inappropriate or unnecessary medications and offers guidance on safely deprescribing, thereby minimizing medication-related risks.
In a controlled trial involving 725 residents across five long-term care homes in New Brunswick, the use of MedSafer led to a significant reduction in inappropriate medications. Specifically, clinicians deprescribed medications in 36% of cases when using the tool—nearly triple the rate observed without it. This advancement is crucial because many seniors are prescribed five or more medications daily, increasing the risk of adverse effects such as falls, confusion, and hospitalizations.
Dr. Emily McDonald, the lead author and associate professor at McGill University, emphasized that medication issues often masquerade as age-related decline, but are instead linked to drug side effects. She recounted cases where stopping sedating medications restored patients' responsiveness and improved communication.
The process of regular medication review is standard in long-term care, typically occurring every three months. However, there's no uniform approach to deprescribing, which MedSafer aims to standardize. The software functions as a checklist, assisting clinicians by highlighting drugs that may no longer be suitable and providing safer alternatives or instructions on cessation.
The problem of 'prescribing cascades'—where side effects from one medication prompt the addition of others—contributes further to overmedication. Addressing this issue proactively can reduce fall risks, confusion, and hospital visits among the elderly.
The developers, Drs. McDonald and Todd Lee, are aiming to integrate MedSafer more broadly into primary care settings. The ultimate goal is to prevent unnecessary medication use before patients require long-term care, making deprescribing a standard part of aging healthcare.
This study, published in JAMA Network Open, underscores the potential of digital tools to enhance medication safety and improve quality of life for older adults. As McDonald states, no older adult should be subjected to medications that cause more harm than benefit.
Source: Read more
Additional details in the original study in JAMA Network Open.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Medicaid and Cancer Screening: Trends, Barriers, and Strategies in New Jersey
New Jersey's Medicaid program is pivotal in increasing cancer screening rates, but barriers remain. Recent research highlights progress, challenges, and strategies to improve early detection through culturally competent outreach and policy support.
Discovery of Specialized Lung Cells Accelerates Repair After Smoke and Virus Exposure in Mice
Scientists have identified rare lung neuroendocrine cells that trigger rapid repair after exposure to smoke and viruses, with potential implications for respiratory health and metabolic disease prevention.
Using Happy Music as a Natural Remedy for Motion Sickness Recovery
Research indicates that listening to cheerful and soothing music can significantly reduce symptoms of motion sickness, offering a natural and non-invasive remedy to enhance travel comfort.
Breakthrough in Childhood Leukemia Treatment: New Drug Combination Shows Promise
A groundbreaking drug combination developed by Cambridge scientists shows promise in treating childhood leukemia more effectively and with fewer side effects, potentially transforming future therapies.